Profile cover photo
Profile photo
OzMS
79 followers -
Australian Multiple Sclerosis News, Information and Community
Australian Multiple Sclerosis News, Information and Community

79 followers
About
Posts

Post has attachment
Public

Post has attachment
Public
MS Research Australia has been reporting on every step that Ocrevus a new MS medication, has taken on its journey to become the first ever approved treatment for progressive MS and relapsing MS in Australia. In July, Ocrevus reached another milestone, it was listed on the PBS for relapsing MS. MS Research Australia is continuing to advocate for Ocrevus’s inclusion on the PBS for progressive MS, and is calling on the MS community to add its voice in the call for its inclusion.

Australia has moved swiftly and positively for people with MS in regards to Ocrevus (ocreluzimab) and is the second country in the world, after the U.S, to approve this very important therapy. Ocrevus has been recommended for listing on the Pharmaceutical Benefits Scheme (PBS) for relapsing MS. Now we await with great anticipation the outcome of the Pharmaceutical Benefits Advisory Committee meeting in November this year where Ocrevus will be considered for listing on the PBS for primary progressive MS.

#ovrevus #ppms #primaryprogressive #ocrelizumab #australia #multiplesclerosis #ms #pbs

Post has attachment
Public
WA Premier Mark McGowan has offered a state funeral for Cuthbert, who had multiple sclerosis and had used a wheelchair for many years.

#bettycuthbert #goldengirl #multiplesclerosis #rip

Post has attachment
Public
I just received an email from a pwMS about the good news down-under (see press release below). Let's hope the EMA & NICE have provide similar cheer for people living with PPMS in Europe and England, respectively. I wonder if other HTAs accepting the results of the ocrelizumab in PPMS trial (ORATORIO) and licensing ocrelizumab for PPMS, puts pressure on the EMA? I suspect not. To help, please have your say and complete the survey below. Thank you.

#ocrevus #ocrelizumab #ppms #australia

Post has attachment
Public
At the November meeting of the Pharmaceutical Benefits Advisory Committee (PBAC), Zinbryta (daclizumab), a new medication for the treatment of relapsing remitting MS received positive recommendations for inclusion on the Pharmaceutical Benefits Scheme (PBS).

#zinbryta   #daclizumab   #pbs   #medication   #rrms   #multiplesclerosis  

Post has attachment
Please Donate if you can, let's try to reach the goal, any amount is much appreciated :)

#donation   #donate   #multiplesclerosis   #support   #information   #website  

Post has attachment
I use this brand from iHerb for my Vitamin D3 supplementation!

Healthy Origins, Vitamin D3, 5,000 IU, 360 Softgels

#iHerb   #healthyorigins   #vitamind3   #vitamind   #multiplesclerosis  

Post has attachment
Medicinal Marijuana for MS in New South Wales
Well now, looky here, Australia finally has at least one State where Medicinal Marijuana will be offered to those who have a need for it! "The NSW government has just passed legislation
that now makes medicinal marijuana or medicinal cannabis legal in New ...

Post has attachment
The NSW government has just passed legislation that now makes medicinal marijuana or medicinal cannabis legal in New South Wales. The legalisation was the result of amendments to the state’s Poisons and Therapeutic Goods Regulations.

#medicinalmarijuana   #multiplesclerosis   #nsw   #australia  

Post has attachment
Each year, MS Research Australia is only able to fund a portion of the many worthy research projects presented. It is, therefore, crucial that we focus our efforts and our donors’ funds not only on the strongest research projects and the most capable researchers, but also on those projects that are viewed as a priorities within the MS community.

#survey   #msra   #research   #australia   #multiplesclerosis  
Wait while more posts are being loaded